Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Haig, C. et al. (2019) Current smoking and prognosis after acute ST-segment elevation myocardial infarction: new pathophysiological insights. JACC: Cardiovascular Imaging, 12(6), pp. 993-1003. (doi:10.1016/j.jcmg.2018.05.022) (PMID:30031700) (PMCID:PMC6547246)

Welsh, P. , Papacosta, O., Ramsay, S., Whincup, P., McMurray, J. , Wannamethee, G. and Sattar, N. (2019) High sensitivity troponin T and incident heart failure in older men: British Regional Heart Study. Journal of Cardiac Failure, 25(4), pp. 230-237. (doi:10.1016/j.cardfail.2018.08.002) (PMID:30103019)

Maznyczka, A. M. et al. (2019) Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart, 6(1), e000979. (doi:10.1136/openhrt-2018-000979) (PMID:31168381) (PMCID:PMC6519583)

Carberry, J. et al. (2018) Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes. JACC: Cardiovascular Imaging, 11(9), pp. 1248-1256. (doi:10.1016/j.jcmg.2017.08.027) (PMID:29153575) (PMCID:PMC6130225)

Carrick, D. et al. (2018) Hypertension, microvascular pathology and prognosis after an acute myocardial infarction. Hypertension, 72(3), pp. 720-730. (doi:10.1161/HYPERTENSIONAHA.117.10786) (PMID:30012869) (PMCID:PMC6080885)

Welsh, P. et al. (2018) Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. European Journal of Heart Failure, 20(2), pp. 268-277. (doi:10.1002/ejhf.988) (PMID:28960777)

Carberry, J. et al. (2017) Persistence of infarct zone T2 hyperintensity at 6 months after acute ST-elevation myocardial infarction: incidence, pathophysiology and prognostic implications. Circulation: Cardiovascular Imaging, 10(12), e006586. (doi:10.1161/CIRCIMAGING.117.006586) (PMID:29242240) (PMCID:PMC5753833)

Wannamethee, S. G., Welsh, P. , Papacosta, O., Ellins, E. A., Halcox, J. P.J., Whincup, P. H. and Sattar, N. (2017) Circulating soluble receptor for advanced glycation end product: cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis, 264, pp. 36-43. (doi:10.1016/j.atherosclerosis.2017.07.008) (PMID:28759844) (PMCID:PMC5603971)

Carrick, D. et al. (2016) Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, 134(23), pp. 1833-1847. (doi:10.1161/CIRCULATIONAHA.116.022603) (PMID:27803036) (PMCID:PMC5131697)

Preiss, D. , Rankin, N. , Welsh, P. , Holman, R.R., Kangas, A.J., Soininen, P., Würtz, P., Ala-Korpela, M. and Sattar, N. (2016) Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study. Diabetic Medicine, 33(11), pp. 1569-1574. (doi:10.1111/dme.13097) (PMID:26887663)

Welsh, P. , Tuckwell, K., McInnes, I. B. and Sattar, N. (2016) Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis, 254, pp. 167-171. (doi:10.1016/j.atherosclerosis.2016.10.016) (PMID:27744141) (PMCID:PMC5110649)

Willeit, P. et al. (2016) Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes and Endocrinology, 4(10), pp. 840-849. (doi:10.1016/S2213-8587(16)30196-6) (PMID:27599814) (PMCID:PMC5035346)

Carberry, J. et al. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68(2), pp. 385-391. (doi:10.1161/HYPERTENSIONAHA.116.07222) (PMID:27354423) (PMCID:PMC4956675)

Wannamethee, S. G., Welsh, P. , Lennon, L., Papacosta, O., Whincup, P. and Sattar, N. (2016) Copeptin and risk of incident stroke, coronary heart disease and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study. Diabetologia, 59(p), pp. 1904-1912. (doi:10.1007/s00125-016-4011-7) (PMID:27312697) (PMCID:PMC4969339)

Welsh, P. et al. (2016) Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA Trial. International Journal of Obesity, 40(6), pp. 1005-1011. (doi:10.1038/ijo.2016.35) (PMID:26927315) (PMCID:PMC4892347)

Wannamethee, G., Shaper, G., Papacosta, O., Lennon, L., Welsh, P. and Whincup, P. (2016) Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men—the British regional heart study. Thorax, 71(6), pp. 526-534. (doi:10.1136/thoraxjnl-2014-206724) (PMID:26811343) (PMCID:PMC4893123)

Carrick, D. et al. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. (doi:10.1172/jci.insight.85768) (PMID:27699259) (PMCID:PMC5033815)

Carrick, D. et al. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37(13), pp. 1044-1059. (doi:10.1093/eurheartj/ehv372) (PMID:26261290) (PMCID:PMC4816961)

Loomis, A. K. et al. (2016) Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. Journal of Clinical Endocrinology and Metabolism, 101(3), pp. 945-952. (doi:10.1210/jc.2015-3444) (PMID:26672639) (PMCID:PMC4803162)

Welsh, P. et al. (2016) Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension, 2016(67), pp. 309-315. (doi:10.1161/HYPERTENSIONAHA.115.06501) (PMID:26667414) (PMCID:PMC4716288)

Carrick, D. et al. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9(1), e004148. (doi:10.1161/CIRCIMAGING.115.004148) (PMID:26763281) (PMCID:PMC4718183)

Carrick, D. et al. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8(7), pp. 779-789. (doi:10.1016/j.jcmg.2015.03.007) (PMID:26093923) (PMCID:PMC4509710)

Welsh, P. et al. (2014) Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia, 57(12), pp. 2513-2520. (doi:10.1007/s00125-014-3383-9) (PMID:25264116)

Rankin, N. J. , Preiss, D. , Welsh, P. , Burgess, K. E.V., Nelson, S. M. , Lawlor, D. A. and Sattar, N. (2014) The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis, 237(1), pp. 287-300. (doi:10.1016/j.atherosclerosis.2014.09.024) (PMID:25299963) (PMCID:PMC4232363)

Welsh, P. et al. (2014) Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients With type 2 diabetes? Results from the ADVANCE Trial. Diabetes Care, 37(8), pp. 2202-2210. (doi:10.2337/dc13-2625)

Welsh, P. , Poulter, N. R., Chang, C. L., Sever, P. S. and Sattar, N. (2014) The Value of N-Terminal Pro–B-Type Natriuretic Peptide in Determining Antihypertensive Benefit: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension, 63(3), pp. 507-513. (doi:10.1161/HYPERTENSIONAHA.113.02204)

Goya Wannamethee, S., Welsh, P. , Whincup, P. H., Lennon, L., Papacosta, O. and Sattar, N. (2014) N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. European Journal of Heart Failure, 16(1), pp. 25-32. (doi:10.1093/eurjhf/hft124)

Hillis, G. S. et al. (2014) The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care, 37(1), pp. 295-303. (doi:10.2337/dc13-1165)

Mirjafari, H. et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Annals of the Rheumatic Diseases, 73(4), pp. 684-690. (doi:10.1136/annrheumdis-2012-202848)

Welsh, P. , Smith, K. and Nelson, S. M. (2014) A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Human Reproduction, 29(5), pp. 1035-1041. (doi:10.1093/humrep/deu036) (PMID:24578473)

Feinkohl, I. et al. (2013) Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care, 36(9), pp. 2779-2786. (doi:10.2337/dc12-2241)

This list was generated on Fri Oct 18 10:07:35 2019 BST.